BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9136959)

  • 1. Relapse of Philadelphia chromosome positive acute lymphoblastic leukaemia after marrow transplantation: sustained molecular remission after early and dose-escalating infusion of donor leucocytes.
    Keil F; Kalhs P; Haas OA; Fritsch G; Reiter E; Mannhalter C; Lechner K; Leitner G; Greinix HT
    Br J Haematol; 1997 Apr; 97(1):161-4. PubMed ID: 9136959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eradication of residual bcr-abl-positive clones by inducing graft-versus-host disease after allogeneic stem cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Matsue K; Tabayashi T; Yamada K; Takeuchi M
    Bone Marrow Transplant; 2002 Jan; 29(1):63-6. PubMed ID: 11840146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red blood cell phenotyping is a sensitive technique for monitoring chronic myeloid leukaemia patients after T-cell-depleted bone marrow transplantation and after donor leucocyte infusion.
    Schaap N; Schattenberg A; Bär B; Mensink E; de Man A; Geurts van Kessel A; de Witte T
    Br J Haematol; 2000 Jan; 108(1):116-25. PubMed ID: 10651734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor leukocyte infusion for leukemic relapse after allogeneic marrow transplantation: lack of residual donor hematopoiesis predicts aplasia.
    Keil F; Haas OA; Fritsch G; Kalhs P; Lechner K; Mannhalter C; Reiter E; Niederwieser D; Hoecker P; Greinix HT
    Blood; 1997 May; 89(9):3113-7. PubMed ID: 9129013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In relapsed patients after lymphocyte depleted bone marrow transplantation the percentage of donor T lymphocytes correlates well with the outcome of donor leukocyte infusion.
    Schattenberg A; Schaap N; Van De Wiel-Van Kemenade E; Bär B; Preijers F; Van Der Maazen R; Roovers E; De Witte T
    Leuk Lymphoma; 1999 Jan; 32(3-4):317-25. PubMed ID: 10037029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for adults with Philadelphia-chromosome-positive acute lymphoblastic leukaemia in remission treated with allogeneic bone marrow transplantation: the potential of real-time quantitative reverse-transcription polymerase chain reaction.
    Lee S; Kim DW; Cho B; Kim YJ; Kim YL; Hwang JY; Park YH; Shin HJ; Park CY; Min WS; Kim HK; Kim CC
    Br J Haematol; 2003 Jan; 120(1):145-53. PubMed ID: 12492591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of leukemia relapsed after allogenic bone marrow transplantation with donor lymphocyte infusion: report of 11 cases].
    Sanz Rodríguez C; Steegmann JL; Granda A; de la Cámara R; Figuera A; Arranz R; Gómez-García de Soria V; Alegre A; Fernández-Rañada JM
    Sangre (Barc); 1999 Dec; 44(6):456-63. PubMed ID: 10822760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation.
    Bär BM; Schattenberg A; Mensink EJ; Geurts Van Kessel A; Smetsers TF; Knops GH; Linders EH; De Witte T
    J Clin Oncol; 1993 Mar; 11(3):513-9. PubMed ID: 8445426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor lymphocyte infusion for childhood acute lymphoblastic leukaemia relapsing after bone marrow transplantation.
    Atra A; Millar B; Shepherd V; Shankar A; Wilson K; Treleaven J; Pritchard-Jones K; Meller ST; Pinkerton CR
    Br J Haematol; 1997 Apr; 97(1):165-8. PubMed ID: 9136960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: indications and dose escalation.
    Shiobara S; Nakao S; Ueda M; Yamazaki H; Takahashi S; Asano S; Yabe H; Kato S; Imoto S; Maruta A; Yoshida T; Gondo H; Morishima Y; Kodera Y
    Ther Apher; 2001 Feb; 5(1):40-5. PubMed ID: 11258609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful prevention of hematological relapse for a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic bone marrow transplantation by donor leukocyte infusion.
    Yazaki M; Andoh M; Ito T; Ohno T; Wada Y
    Bone Marrow Transplant; 1997 Feb; 19(4):393-4. PubMed ID: 9051252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The monitoring of BCR-ABL mRNA by reverse transcription PCR in patients undergoing allogeneic bone marrow transplantation for acute lymphoblastic leukemia with a positive Philadelphia chromosome].
    Román J; Castillejo JA; Jiménez A; Maldonado J; Torres A
    Med Clin (Barc); 1999 Dec; 113(20):779-82. PubMed ID: 10680143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
    J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of hematological and extramedullary relapse of MLL-positive acute lymphoblastic leukemia after bone marrow transplantation using donor leukocyte infusion.
    Patriarca F; Sperotto A; Skert C; Damiani D; Prosdocimo S; Fanin R
    Ann Hematol; 2004 Oct; 83(10):667-9. PubMed ID: 15300405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of residual disease and guided donor leucocyte infusion after allogeneic bone marrow transplantation by chimaerism analysis with short tandem repeats.
    de Weger RA; Tilanus MG; Scheidel KC; van den Tweel JG; Verdonck LF
    Br J Haematol; 2000 Sep; 110(3):647-53. PubMed ID: 10997977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse.
    Miglino M; Berisso G; Grasso R; Canepa L; Clavio M; Pierri I; Pietrasanta D; Gatto S; Varaldo R; Ballerini F; Verdiani S; Casarino L; DeStefano F; Sessarego M; Dominietto A; Raiola AM; Bregante S; di Grazia C; Gobbi M; Bacigalupo A
    Bone Marrow Transplant; 2002 Nov; 30(9):579-85. PubMed ID: 12407432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation.
    Glass B; Majolino I; Dreger P; Scimè R; Santoro A; Vasta S; Suttorp M; Haferlach T; Schmitz N
    Bone Marrow Transplant; 1997 Oct; 20(7):533-41. PubMed ID: 9337054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extramedullary relapse after favorable molecular response to donor leukocyte infusions for recurring acute leukemia.
    Berthou C; Léglise MC; Herry A; Balcon D; Hardy E; Lessard M; Abgrall JF
    Leukemia; 1998 Nov; 12(11):1676-81. PubMed ID: 9823940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor leukocyte infusion as salvage therapy in an adult with relapsed acute lymphoblastic leukemia after allogeneic bone marrow transplantation.
    Chang CS; Lin SF; Liu TC; Huang SM; Chen TP
    J Formos Med Assoc; 1998 Jan; 97(1):55-8. PubMed ID: 9481066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
    Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
    Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.